Annual Meeting Sessions Approved for CPEs
We are excited to announce the following sessions, held during the general NASPGHAN Annual Meeting, were approved for CPEUs as an added value to our members.
Monday, November 2
Concurrent Session I - 1:00 PM-2:30 PM ET
Medical management of intestinal failure
Moderators: Debora Duro, MD, MS, Salah Foundation Children's Hospital and Charles Vanderpool, MD, Riley Hospital for Children
1:00 PM Mitigating risk and managing intestinal failure associated liver disease in children: The role of parenteral lipids
Justine Turner, MD, PhD, Edmonton Clinic Health Academy
Learning Objectives:
- Define the pediatric population at risk of intestinal failure associated liver disease/IFALD.
- Define the role of parenteral lipids in developing children.
- Review the advantages and disadvantages of current parenteral lipid strategies for treatment and prevention of IFALD.
- Consider what would be the ideal parenteral lipid(s) for children at risk of IFALD.
1:25 PM AN INTERNATIONAL NEEDS ASSESSMENT DESCRIBING THE UTILITY, INTEREST, AND PRIORITIES OF SPECIFIC CARBOHYDRATE DIET EDUCATION AMONGST INDIVIDUALS AND FAMILIES WITH INFLAMMATORY BOWEL DISEASE.
Nancy Rivera, MD, MS, Lucile Packard Children's Hospital Stanford
1:37 PM The Challenging intestinal failure patient
Valeria Cohran, MD, Ann & Robert H Lurie Children's Hospital
Learning Objectives:
- The participant should be able to assess and manage feeding intolerance.
- The participant should know the indications for teduglutide in patients with intestinal failure.
- The participant will identify the indications for endoscopy and surgery in the care of children with intestinal failure.
2:02 PM A Placebo Controlled Exploratory Study to Identify Biomarkers in Food Tolerance - NASPGHAN Foundation/Abbott Nutrition Advanced Fellowship Training in Pediatric Nutrition
Bridget Dowd, MD, Children's Hospital of Philadelphia
Monday, November 2
Concurrent Session II - 3:00 PM-4:30 PM ET
Obesity - when to intervene, what's available, what works
Moderators: Catherine Larson-Nath, MD, University of Minnesota and Mark Corkins, MD, CNSC, SPR, FAAP, University of Tennessee Health Science Center
3:00 PM Current guidelines for the treatment of pediatric obesity: A focus on empirically supported behavioral interventions
Ann Davis, PhD, MPH, ABPP, KU Medical Center
3:25 PM The weight of the world: The role of the RD in obesity treatment
Sharon Weston, MS, RD, LDN, Boston Children’s Hospital
Learning Objectives:
- Determine cutoffs for pediatric obesity and severe obesity using BMI percentiles and % 95th percentile BMI criteria.
- Describe at least 3 dietary questions which can be used to assess current eating pattern and diagnose problem areas.
- Describe health behaviors which can be focused on rather than body weight as part of the nutrition intervention.
3:50 PM Sugar Metabolism in Fatty Liver Disease - NASPGHAN Foundation/Nestlé Nutrition Research Young Investigator Development Award
Samir Softic, MD, University of Kentucky College of Medicine
4:02 PM Medical management of obesity and it's complications
Miriam Vos, MD, MSPH, Emory University